AR080497A1 - Heterociclos radiomarcados con yodo,utiles para diagnosticar la enfermedad de alzheimer - Google Patents

Heterociclos radiomarcados con yodo,utiles para diagnosticar la enfermedad de alzheimer

Info

Publication number
AR080497A1
AR080497A1 ARP110100767A ARP110100767A AR080497A1 AR 080497 A1 AR080497 A1 AR 080497A1 AR P110100767 A ARP110100767 A AR P110100767A AR P110100767 A ARP110100767 A AR P110100767A AR 080497 A1 AR080497 A1 AR 080497A1
Authority
AR
Argentina
Prior art keywords
iodine
disease
useful
diagnosing alzheimer
radiomarced
Prior art date
Application number
ARP110100767A
Other languages
English (en)
Inventor
Heribert Schmitt
Tobias Heinrich
Damian Brockschnieder
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of AR080497A1 publication Critical patent/AR080497A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002Heterocyclic compounds

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Compuestos radiomarcados con yodo que son utiles para diagnosticar la enfermedad de Alzheimer. Precursores respectivos para la síntesis de dichos compuestos. Proceso agentes para el diagnostico por imágenes para manufacturar dichos. Reivindicacion 1: Un compuesto caracterizado porque es de formula (1), donde - Q es un anillo aromático de seis miembros, carbocíclico o bien heterociclo con un átomo de N, donde X1, X2, X3, X4 y X5 se seleccionan en forma independiente entre N o C, y donde cero o uno de X1, X2, X3, X4 o X5 es N y los restantes son C; - A es Sn(alquilo)3, I, I-123, I-124, I-125, I-131, o bien Br; alquilo comprende metilo, etilo, propilo, butilo, pentilo y hexilo, - Y es C o N; con la condicion de que si X1, X2, X3, X4 o X5 tiene el valor N, se excluye la sustitucion con A en esa posicion; o una sal farmacéuticamente aceptable del mismo.
ARP110100767A 2010-03-11 2011-03-11 Heterociclos radiomarcados con yodo,utiles para diagnosticar la enfermedad de alzheimer AR080497A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10075112 2010-03-11

Publications (1)

Publication Number Publication Date
AR080497A1 true AR080497A1 (es) 2012-04-11

Family

ID=43969390

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110100767A AR080497A1 (es) 2010-03-11 2011-03-11 Heterociclos radiomarcados con yodo,utiles para diagnosticar la enfermedad de alzheimer

Country Status (3)

Country Link
AR (1) AR080497A1 (es)
TW (1) TW201134492A (es)
WO (1) WO2011110511A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103724207B (zh) * 2013-12-20 2016-07-06 北京智博高科生物技术有限公司 苯基苄基醚类衍生物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY27003A1 (es) * 2000-11-06 2002-07-31 Schering Ag Productos radiofarmacéuticos para el diagnóstico de la enfermedad de alzheimer
EP2163541A1 (en) * 2008-09-12 2010-03-17 Bayer Schering Pharma Aktiengesellschaft Piperazine derivatives for binding and imaging amyloid plaques and their use

Also Published As

Publication number Publication date
TW201134492A (en) 2011-10-16
WO2011110511A1 (en) 2011-09-15

Similar Documents

Publication Publication Date Title
AR121016A2 (es) Sales de fenotiazindiaminio y su uso
AR071385A1 (es) Compuestos de 2-imino-3-metil pirrolopirimidinona sustituida con tiofenilo,composiciones farmaceuticas que los contienen,y uso de los mismos para el tratamiento de patologias asociadas con la proteina beta amiloide,tales como alzheimer y otros formas de demencia.
AR083760A1 (es) Agentes antibacterianos y composiciones farmaceuticas
MA38935B1 (fr) Dérivés de diazacarbazole à titre de ligands tau-pet
MA38540A1 (fr) Dérivés de naphtyridine utiles comme antagonistes de l'intégrine alpha-v-bêta-6
AR098912A1 (es) Inhibidores de syk
AR083849A1 (es) Antagonistas de mdm2 de espiro-oxindol
EA201690019A1 (ru) Производное аминотриазина и содержащая его фармацевтическая композиция
EA201100698A1 (ru) Производные тиенотриазолодиазепина, активные в отношении апо а1
MA35245B1 (fr) Pyridin-2-amides utiles comme agonistes de cb2
HRP20090235A2 (en) Carbonylated (aza) cyclohexanes as dopamine d3 receptor ligands
ME01992B (me) Jedinjenje diarilhidantoina
RU2016112547A (ru) Имидазо[1,2-а]пиридин-7-амины в качестве средств визуализации
MA35086B1 (fr) Compose de triazolopyridine
AR081426A1 (es) Derivados de pirazol inhibidores del receptor sigma
CY1113873T1 (el) Παραγωγα hydroxybenzamide σαν παραγοντες καταστολης της hsp90
AR075583A1 (es) Derivados de isoxazol/o-piridina con eslabon etilo o etenilo
BR112014026266A2 (pt) derivado de quinazolidinadiona
CR10842A (es) Derivados de acetileno y su uso para la union a placas amiloides y su diagnostico por imagenes
CO6251201A2 (es) Composiciones y metodos para el tratamiento de3 enfermedades y desordenes oftalmicos
RU2012148909A (ru) Новый синтез соединений тиазолидиндиона
AR067770A1 (es) Derivados de tiazol y ditiazol para el tratamiento de diabetes
EA200901142A1 (ru) 18f фторбензоильные меченые биологически активные соединения в качестве диагностических визуализирующих средств, а также бензотриазол-1-илоксибензоильные, 2,5-(диоксопирролидин-1-илокси)бензоильные и триметиламмониобензоильные предшественники
AR065599A1 (es) Benzotiofenos y benzofuranos 2- heteroarilo sustituidos
RU2012144438A (ru) Производные 1-(2-фторбифенил-4-ил)-алкилкарбоновой кислоты для лечения транстиретинового амилоидоза

Legal Events

Date Code Title Description
FB Suspension of granting procedure